Marjorie Pizarro-Guajardo1, María Cristina Ravanal2,3, Maria Daniela Paez4, Eduardo Callegari4, Daniel Paredes-Sabja1. 1. Microbiota-Host Interactions and Clostridia Research Group, Facultad de Ciencias Biológicas, Department of Biological Sciences, Universidad Andrés Bello, Santiago, 8370146, Chile. 2. Center for Bioinformatics and Integrative Biology, Facultad de Ciencias Biológicas, Universidad Andrés Bello, Santiago, 8370146, Chile. 3. Instituto de Ciencia y Tecnología de los Alimentos, Facultad de Ciencias Agrarias, Universidad Austral de Chile, Isla Teja, Valdivia, 5090000, Chile. 4. SD-BRIN Proteomics Core Facility, Sanford School of Medicine, University of South Dakota,, Vermillion, SD, 57069, USA.
Abstract
PURPOSE: Clostridium difficile infections are the leading cause of diarrhea associated with the use of antibiotics. During infection, C. difficile initiates a sporulation cycle leading to the persistence of C. difficile spores in the host and disease dissemination. The development of vaccine and passive immunization therapies against C. difficile has focused on toxins A and B. In this study, an immunoproteome-based approach to identify immunogenic proteins located on the outer layers of C. difficile spores as potential candidates for the development of immunotherapy and/or diagnostic methods against this devastating infection is used. EXPERIMENTAL DESIGN: To identify potential immunogenic proteins on the surface of C. difficile R20291, spore coat/exosporium extracts are separated by 2D electrophoresis (2-DE) and analyzed for reactivity against C. difficile spore-specific goat sera. Finally, the selected spots are in-gel digested with chymotrypsin, peptides generated are separated by nanoUPLC followed by MS/MS using Quad-TOF-MS, corroborated by Ultimate 3000RS-nano-UHPLC coupled to Q-Exactive-Plus-Orbitrap MS. RESULTS: The analysis identify five immunoreactive proteins: spore coat proteins CotE, CotA, and CotCB; exosporium protein CdeC; and a cytosolic methyltransferase. CONCLUSION: This data provides a list of spore surface protein candidates as antigens for vaccine development against C. difficile infections.
PURPOSE:Clostridium difficile infections are the leading cause of diarrhea associated with the use of antibiotics. During infection, C. difficile initiates a sporulation cycle leading to the persistence of C. difficile spores in the host and disease dissemination. The development of vaccine and passive immunization therapies against C. difficile has focused on toxins A and B. In this study, an immunoproteome-based approach to identify immunogenic proteins located on the outer layers of C. difficile spores as potential candidates for the development of immunotherapy and/or diagnostic methods against this devastating infection is used. EXPERIMENTAL DESIGN: To identify potential immunogenic proteins on the surface of C. difficile R20291, spore coat/exosporium extracts are separated by 2D electrophoresis (2-DE) and analyzed for reactivity against C. difficile spore-specific goat sera. Finally, the selected spots are in-gel digested with chymotrypsin, peptides generated are separated by nanoUPLC followed by MS/MS using Quad-TOF-MS, corroborated by Ultimate 3000RS-nano-UHPLC coupled to Q-Exactive-Plus-Orbitrap MS. RESULTS: The analysis identify five immunoreactive proteins: spore coat proteins CotE, CotA, and CotCB; exosporium protein CdeC; and a cytosolic methyltransferase. CONCLUSION: This data provides a list of spore surface protein candidates as antigens for vaccine development against C. difficile infections.
Authors: Patima Permpoonpattana; Jutarop Phetcharaburanin; Anna Mikelsone; Marcin Dembek; Sisareuth Tan; Marie-Clémence Brisson; Roberto La Ragione; Alain R Brisson; Neil Fairweather; Huynh A Hong; Simon M Cutting Journal: J Bacteriol Date: 2013-01-18 Impact factor: 3.490
Authors: Grace S Crowther; Caroline H Chilton; Chris Longshaw; Sharie L Todhunter; Duncan Ewin; Jonathan Vernon; Andreas Karas; Mark H Wilcox Journal: J Antimicrob Chemother Date: 2016-01-10 Impact factor: 5.790
Authors: Laura J Deakin; Simon Clare; Robert P Fagan; Lisa F Dawson; Derek J Pickard; Michael R West; Brendan W Wren; Neil F Fairweather; Gordon Dougan; Trevor D Lawley Journal: Infect Immun Date: 2012-05-21 Impact factor: 3.441
Authors: E Ling; G Feldman; M Portnoi; R Dagan; K Overweg; F Mulholland; V Chalifa-Caspi; J Wells; Y Mizrachi-Nebenzahl Journal: Clin Exp Immunol Date: 2004-11 Impact factor: 4.330
Authors: Brenda Lucila Jofre; Ricardo Javier Eliçabe; Juan Eduardo Silva; Juan Manuel Pérez Sáez; Maria Daniela Paez; Eduardo Callegari; Karina Valeria Mariño; María Silvia Di Genaro; Gabriel Adrián Rabinovich; Roberto Carlos Davicino Journal: Biomolecules Date: 2021-11-04